vestibular neuritis
Conditions
Interventions
Oral administration with prednisolone at tapering doses from 60 mg for 9 days within a month of the onset of vestibular neuritis
Sponsors
Monistry of Education, Culture, Sports Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult patients at ages fron 20 to 80 years old, who suffered from vestibular neuritis, but not Meniere's disease and benign paroxysmal positional vertigo, within a month of the onset
Exclusion criteria
Exclusion criteria: 1) Patients who suffered from episodic vertigo 2) Patients who was excluded by investigators 3) Patients who suffered from infectious disease refractory to antibacterial drugs 4) Patients who suffered from peptic ulcer 5) Patients who suffered from psychological disease 6) Patients who suffered from tuberculosis 7) Patients who suffered from corneitis due to HSV 8) Patients who suffered from cataracta 9) Patients who suffered from glaucoma 10) Patients who suffered from hypertension 11) Patients who suffered from electrolyte abnormality 12) Patients who suffered from thrombosis 13) Patients who suffered after recent visceral operation 14) Patients who suffered from acute cardiac infarction 15) Patients who suffered from prednisolone intolerance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DHI scores and canal paresis percentages in caloric test | — |
Secondary
| Measure | Time frame |
|---|---|
| Spontaneous, positional and positioning nystagmus, hearing levels, and findings of VEMP (vestibular myogenic myogenic potential) and vHIT (video Head Impulse Test). | — |
Countries
Japan
Contacts
Public ContactNoriaki Takeda
University of Tokushima School of Medicine Department of Otolaryngology
Outcome results
None listed